J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mixed, with the Dow Jones index falling more than 200 points on Tuesday.

Shares of The J. M. Smucker Company (NYSE:SJM) rose sharply during Tuesday's session after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance with its midpoint above estimates.

Smucker shares surged 6.2% to $120.60 on Tuesday.

Here are some other big stocks recording gains in today's session.

Hesai Group (NASDAQ:HSAI) shares jumped 59% to $7.55 after the company reported better-than-expected third-quarter sales results.
Embecta Corp. (NASDAQ:EMBC) gained 30.2% to $18.76 after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates.
LexinFintech Holdings Ltd. (NASDAQ:LX) surged 22.8% to $4.1750 after the company announced its board approved an amendment for a dividend policy to increase the payout ratio. Also, the company reported third-quarter financial results.
Semtech Corporation (NASDAQ:SMTC) gained 20.3% to $64.32 as the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance with its midpoint above estimates.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) gained 18.1% to $22.17 after the company entered into a global licensing and collaboration agreement with Sarepta Therapeutics for multiple clinical and preclinical siRNA programs.
Neurogene Inc. (NASDAQ:NGNE) shares rose 15% to $25.65.
SmartRent, Inc. (NYSE:SMRT) gained 13.8% to $1.8450.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) gained 12.6% to $2.1850.
POET Technologies Inc. (NASDAQ:POET) surged 12.2% to $4.77. POET Technologies recently announced plans to expand its capacity.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares gained 9.1% to $125.10 after the company announced a global licensing and collaboration agreement with Arrowhead Pharmaceuticals for multiple clinical and preclinical siRNA programs.
NRG Energy, Inc. (NYSE:NRG) gained 8% to $99.21 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $93 to $113.
Exact Sciences Corporation (NASDAQ:EXAS) surged 7.8% to $59.45. The company announced it will present 10 abstracts at SABCS.
Woodward, Inc. (NASDAQ:WWD) surged 7.4% to $192.62 after the company reported better-than-expected fourth-quarter EPS and sales.
Rocket Lab USA, Inc. (NASDAQ:RKLB) gained 7.3% to $25.82.
Hanesbrands Inc. (NYSE:HBI) gained 5.8% to $8.94. UBS analyst Jay Sole upgraded Hanesbrands from Neutral to Buy and raised the price target from $9 to $11.